Raised tattoos in a human immunodeficiency virus-infected patient;Sobreelevación de tatuaje en un paciente infectado por virus de la inmunodeficiencia humana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue 10, 2009, Pages 602-604

  García Lázaro, Milagros ^a   Villar, Carlos ^a   Natera, Clara ^a   Rivero, Antonio ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR; MEGLUMINE ANTIMONATE; PENTAMIDINE; RITONAVIR; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONSULTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MALE; SKIN BIOPSY; TATTOO; VISCERAL LEISHMANIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; HEPATITIS C, CHRONIC; HISTIOCYTES; HUMANS; LAMIVUDINE; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PATIENT COMPLIANCE; PENTAMIDINE; PYRIMIDINONES; RECURRENCE; RITONAVIR; TATTOOING; ZIDOVUDINE;

EID: 70449520456     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2008.11.022     Document Type: Article

References (10)

1. Stark D., Pett S., Marriott D., and Harkness J. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 44 (2006) 1178-1180
2. Ridolfo A.L., Gervasoni C., Antinori S., Pizzuto M., Santambrogio S., Trabattoni D., et al. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect 40 (2000) 199-202
3. Rijal A., Agrawal S., Agarwalla A., Agrawal A., and Rijal S. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: A rare presentation. Int J Dermatol 44 (2005) 494-496
4. Mbui J., Rashid R., Lodenyo H., Nyakundi P., Kipmutai R., Mutuma G., et al. Visceral leishmaniasis with concomittant post kala-azar dermal leishmaniasis responds to oral sitamaquine: Case report. East Afr Med J 80 (2003) 440-442
5. Bosch R.J., Rodrigo A.B., Sánchez P., De Gálvez M.V., and Herrera E. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol 41 (2002) 670-675
6. Colebunders R., Depraetere K., Verstraeten T., Lambert J., Hauben E., Van Marck E., et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 41 (1999) 847-850
7. Posada-Vergara M.P., Lindoso J.A., Tolezano J.E., Pereira-Chioccola V.L., Silva M.V., and Goto H. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J Infect Dis 192 (2005) 1819-1822
8. Gilad J., Borer A., Hallel-Halevy D., Riesenberg K., Alkan M., and Schlaeffer F. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection. Isr Med Assoc J 3 (2001) 451-452
9. Antinori S., Longhi E., Bestetti G., Piolini R., Acquaviva V., Foschi A., et al. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. Br J Dermatol 157 (2007) 1032-1036
10. Terabe M., Kuramochi T., Ito M., Hatabu T., Sanjoba C., Chang K.P., et al. CD4(+) cells are indispensable for ulcer development in murine cutaneous leishmaniasis. Infect Immun 68 (2000) 4574-4577